QQ客服 官方微博 反馈留言

	Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-gamma expression of T cells in vitro? A prospective, randomized, double-blind study
	Zhou, Naibao; Fu, Zhijian; Li, Hao; Wang, Kaiguo
刊名	MEDICINE
	2017
卷号	96期号:16
关键词	cancer pain IFN-gamma IL-2 ketamine T cells
DOI	10.1097/MD.0000000000006639
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4585854
专题	山东大学
作者单位	1.Shandong Univ, Shandong Prov Hosp, Dept Pain Management, 324 Jingwu Rd, Jinan 250021, Peoples R China. 2.[Zhou, Naibao 3.L
推荐引用方式 GB/T 7714	Zhou, Naibao,Fu, Zhijian,Li, Hao,et al. Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-gamma expression of T cells in vitro? A prospective, randomized, double-blind study[J]. MEDICINE,2017,96(16).
APA	Zhou, Naibao,Fu, Zhijian,Li, Hao,&Wang, Kaiguo.(2017).Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-gamma expression of T cells in vitro? A prospective, randomized, double-blind study.MEDICINE,96(16).
MLA	Zhou, Naibao,et al."Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-gamma expression of T cells in vitro? A prospective, randomized, double-blind study".MEDICINE 96.16(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。